The Medical treatment tourism cagr in 2026 refers to traveling to another country to receive medical treatment, often because of cost savings, shorter waiting times, and access to specialized healthcare services. Patients may travel internationally for dental procedures, cardiac procedures, oncology procedures, orthopedic and spine procedures, and other treatments. The market is gaining momentum as healthcare infrastructure expands in developing countries and advanced technologies become more widely available.
According to Fortune Business Insights, the global medical treatment tourism market size was valued at USD 21.09 billion in 2025. The market is projected to grow from USD 25.87 billion in 2026 to USD 140.88 billion by 2034, exhibiting a CAGR of 23.60% during the forecast period. Europe dominated the market with a 54.08% share in 2025, generating USD 7.54 billion in revenue.
The rising burden of chronic diseases and expanding healthcare infrastructure in emerging countries are major factors supporting market growth. Patients in developed countries may face high treatment costs and long waiting periods, encouraging them to seek timely and affordable medical care abroad. Countries such as Malaysia, Turkey, and India are attracting international patients by offering high-quality treatment at comparatively lower costs and shorter waiting times.
Healthcare infrastructure in emerging markets is also expanding through advanced medical technologies and international accreditations. New facilities are being developed to serve international patients, while technologies such as robotic-assisted surgeries, artificial intelligence-based diagnostics, 3D printing, and real-time analytics are strengthening treatment capabilities.
However, post-operative complications and inadequate follow-up care remain important restraints. Patients returning home soon after surgery may have limited access to the original surgeon and appropriate follow-up services. Long-distance travel after surgery can increase risks such as deep vein thrombosis, infection, and delayed healing. Ethical concerns and insurance limitations also create challenges, as standard health insurance policies may not cover procedures performed abroad.
Leading companies are focusing on expanding healthcare infrastructure, improving treatment offerings, maintaining quality standards, and obtaining international accreditations to attract international patients. Key companies profiled include Apollo Hospitals Enterprise Ltd., Fortis Healthcare, Bumrungrad International Hospital, Charité, Sheba Medical Center, The Johns Hopkins Hospital, ASAN MEDICAL CENTER, Gleneagles Hospitals, Vejthani Hospital, Ranka Hospital, and MELIVA.
Bumrungrad International Hospital received its second Global Healthcare Accreditation accreditation with “Excellence” in March 2024. Other companies are pursuing strategic collaborations and acquisitions to broaden services and strengthen their positions in the international market.
By Service Type (Cardiac Procedures, Oncology Procedures, Orthopedic & Spine Procedures, Dental Procedures, and Others)
By Age Group (Pediatric and Adult)
By Service Provider (Public and Private)
Explore the full research report with detailed insights and TOC:https://www.fortunebusinessinsights.com/medical-treatment-tourism-market-113695
Europe held the leading position in 2025, accounting for 54.08% of the global market and generating USD 7.54 billion. The region is supported by high-quality healthcare infrastructure, advanced technologies, and facilities serving international patients.
North America reached USD 5.76 billion in 2025 and is projected to reach USD 6.98 billion in 2026. Advanced healthcare infrastructure, licensed practitioners, and medical travel initiatives support regional growth.
Asia Pacific generated USD 3.91 billion in 2025. Government initiatives promoting medical tourism are supporting growth across the region. Latin America generated USD 1.83 billion in 2025, while the Middle East & Africa market reached USD 2.05 billion.